Barely Significant

Excerpts

514,629 sentences

nominally significantp = 0.0230.5× alphagold
In unadjusted analyses, only mtDNA haplogroup H showed a nominally significant over-representation in the rapid pain progressors group (43.4%) compared with non-rapid progressors (39.4%) (OR = 1.179; 95%CI = 1.023–1.359; p = 0.023); however, this association did not remain significant after Bonferroni correction (q-value = 0.115).
borderline significantp = 0.0230.5× alphagold
Testing copanlisib exposure variables on the RBCM for PFS in copanlisib‐treated patients only demonstrated a statistically significant, positive ER relationship for PFS for all three time‐varying copanlisib exposure estimates ( C avg,2wk : p = 0.002; C avg,4wk : p = 0.004; C avg,8wk : p = 0.002), along with a borderline significant ( p = 0.023) relationship for copanlisib exposure expressed as time‐invariant AUC (0–168)nd (Figure 3b ), indicating that higher exposure in copanlisib‐treated patients was associated with prolonged PFS.
highly significantP =0.0230.5× alphaqualifiedgold
The difference was highly significant for sorafenib vs. pazopanib in the incidence of all-grade rash (odds ratio [OR] 1.649, 95% CI 1.086–2.505, P =0.023), hand–foot syndrome (OR 3.096, 95% CI 1.271–7.544, P =0.009) and mucositis (OR 4.562, 95% CI 2.132–9.609, P <0.001).